Pharmaceutical and Biotech Portfolio Management: How Easy is it to Spend 10 or 20 Billion? – Enrich Consulting
What is an R&D-driven company with $10-50 billion of cash in the bank to do? In the last twelve months, Merck, Pfizer, HP, AstraZeneca, and Bristol-Myers Squibb have announced stock buybacks totaling over $25 billion, and layoffs of over 30.000 employees. So apparently, for many firms, the best use of their cash hoard is a...